Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy
- PMID: 11134403
- DOI: 10.1212/wnl.55.12.1931
Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy
Abstract
Limb-girdle muscular dystrophy type 2B (LGMD2B) and Miyoshi myopathy (MM) are autosomal recessive disorders caused by mutations in the dysferlin gene on chromosome 2p13. The authors studied a large Russian family with both LGMD2B and MM. All affected individuals, as well as one preclinical boy with dystrophic changes on muscle biopsy, were found to be homozygous for a novel dysferlin mutation, TG573/574AT (Val67Asp). This finding supports the view that additional factors (e.g., modifier genes) contribute to the phenotypic expression of causative mutations in dysferlinopathies.
Similar articles
-
Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).Hum Mol Genet. 1999 May;8(5):871-7. doi: 10.1093/hmg/8.5.871. Hum Mol Genet. 1999. PMID: 10196377
-
Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation.Am J Med Genet. 2000 Apr 10;91(4):305-12. doi: 10.1002/(sici)1096-8628(20000410)91:4<305::aid-ajmg12>3.0.co;2-s. Am J Med Genet. 2000. PMID: 10766988
-
A new dysferlin gene mutation in two Japanese families with limb-girdle muscular dystrophy 2B and Miyoshi myopathy.Neuromuscul Disord. 2001 Mar;11(2):139-45. doi: 10.1016/s0960-8966(00)00168-1. Neuromuscul Disord. 2001. PMID: 11257469
-
Translational research and therapeutic perspectives in dysferlinopathies.Mol Med. 2011 Sep-Oct;17(9-10):875-82. doi: 10.2119/molmed.2011.00084. Epub 2011 May 6. Mol Med. 2011. PMID: 21556485 Free PMC article. Review.
-
[Mutational and clinical features of Japanese patients with dysferlinopathy (Miyoshi myopathy and limb girdle muscular dystrophy type 2B)].Rinsho Shinkeigaku. 2005 Nov;45(11):938-42. Rinsho Shinkeigaku. 2005. PMID: 16447768 Review. Japanese.
Cited by
-
Lysosome fusion to the cell membrane is mediated by the dysferlin C2A domain in coronary arterial endothelial cells.J Cell Sci. 2012 Mar 1;125(Pt 5):1225-34. doi: 10.1242/jcs.094565. Epub 2012 Feb 20. J Cell Sci. 2012. PMID: 22349696 Free PMC article.
-
Nanodysferlins support membrane repair and binding to TRIM72/MG53 but do not localize to t-tubules or stabilize Ca2+ signaling.Mol Ther Methods Clin Dev. 2024 Apr 26;32(2):101257. doi: 10.1016/j.omtm.2024.101257. eCollection 2024 Jun 13. Mol Ther Methods Clin Dev. 2024. PMID: 38779337 Free PMC article.
-
Modifying muscular dystrophy through transforming growth factor-β.FEBS J. 2013 Sep;280(17):4198-209. doi: 10.1111/febs.12266. Epub 2013 Apr 24. FEBS J. 2013. PMID: 23551962 Free PMC article. Review.
-
4-Phenylbutyrate restores localization and membrane repair to human dysferlin mutations.iScience. 2021 Dec 20;25(1):103667. doi: 10.1016/j.isci.2021.103667. eCollection 2022 Jan 21. iScience. 2021. PMID: 35028538 Free PMC article.
-
Distal myopathies.Curr Neurol Neurosci Rep. 2014 Mar;14(3):434. doi: 10.1007/s11910-013-0434-4. Curr Neurol Neurosci Rep. 2014. PMID: 24477389 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases